Mai Capital Management Bio Atla, Inc. Put Options Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BCAB
# of Institutions
46Shares Held
13.9MCall Options Held
20.3KPut Options Held
1.2K-
Acorn Capital Advisors, LLC New York, NY4.03MShares$1.57 Million0.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.82MShares$709,0200.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.69MShares$659,1420.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$535,8890.03% of portfolio
-
Black Rock Inc. New York, NY792KShares$308,7080.0% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $14.2M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...